23/12/201626/01/2024 Helix BioPharma Corp. Successfully Out-Licenses Late Stage BiPhasix Technology admin 0 Comments
22/12/201626/01/2024 Helix BioPharma Corp. Announces The Signing of a Non-Binding Letter of Intent with ProMab Biotechnologies to Develop Cell-Based Therapies admin 0 Comments
13/12/201626/01/2024 Helix BioPharma Corp. Announces Fiscal First Quarter 2017 Results admin 0 Comments
09/12/201626/01/2024 Helix Biopharma Corp. To Present at the Biotech Showcase Conference During the Annual JP Morgan Week in San Francisco admin 0 Comments
06/12/201626/01/2024 Helix BioPharma Corp. Presents Topline L-DOS47 Results at the 17th IASCLC World Conference on Lung Cancer admin 0 Comments
30/11/201626/01/2024 Helix BioPharma Corp. Accelerates Escalation of L-DOS47 Dosing in the US Phase I Study admin 0 Comments
17/11/201626/01/2024 Helix BioPharma Corp. Announces Poster Presentation of L-DOS47 at the World Conference on Lung Cancer admin 0 Comments
27/10/201626/01/2024 Helix BioPharma Corp Presents At National Investment Banking Association admin 0 Comments